Invention Grant
- Patent Title: Method employing bispecific protein complex
-
Application No.: US15779428Application Date: 2016-12-01
-
Publication No.: US10954312B2Publication Date: 2021-03-23
- Inventor: Helene Margaret Finney
- Applicant: UCB BIOPHARMA SRL
- Applicant Address: BE Brussels
- Assignee: UCB BIOPHARMA SRL
- Current Assignee: UCB BIOPHARMA SRL
- Current Assignee Address: BE Brussels
- Agency: Medler Ferro Woodhouse & Mills PLLC
- Priority: GB1521389 20151203
- International Application: PCT/EP2016/079444 WO 20161201
- International Announcement: WO2017/093410 WO 20170608
- Main IPC: G01N33/53
- IPC: G01N33/53 ; G01N33/68 ; C07K16/00 ; C07K16/30 ; C07K16/46 ; C07K14/39 ; A61P35/00 ; C07K16/14 ; A61K39/00

Abstract:
The present invention is directed to a method of controlling and directing cells, for example to stimulate an immune response, inhibit an immune response, direct tissue regeneration or prevent tissue damage for therapeutic activity through the use of heterodimerically-tethered bispecific protein complex of formula A-X:Y-B. Component A may present X on the surface of a cell, may bind a protein (including a marker) expressed on the surface of an effector cell, or A-X is expressed on the surface of an effector cell, whilst B is specific to an epitope on target cell or tissue of interest. X:Y is a heterodimeric-tether which is formed by a binding interaction between X and Y, which together with A and B assists and effects the controlling and directing of the selected cells.
Public/Granted literature
- US20180355063A1 METHOD EMPLOYING BISPECIFIC PROTEIN COMPLEX Public/Granted day:2018-12-13
Information query
IPC分类: